Seelos Therapeutics, Inc. - Company Profile

Powered by

All the data and insights you need on Seelos Therapeutics, Inc. in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Seelos Therapeutics, Inc. Strategy Report

  • Understand Seelos Therapeutics, Inc. position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Seelos Therapeutics, Inc.: Overview

Select Item

Seelos Therapeutics, Inc. (Seelos) is a clinical-stage biopharmaceutical company that focuses on developing novel technologies and therapeutics for the treatment of central nervous system (CNS) and other rare disorders. Its lead programs include SLS-002, SLS-005, and pipeline products include SLS-004, SLS-007, SLS-008, SLS-010 and SLS-012. Seelos pipeline products find application in treating various multiple CNS disorders including parkinson’s disease, sanflippo syndrome, suicidality post-traumatic stress disorders, major depressive disorders and other diseases such as atopic dermatitis, asthma, and pediatric esophagitis. It operates along with its subsidiaries. Seelos is headquartered in New York, the US.

 Gain a 360-degree view of Seelos Therapeutics, Inc. and make more informed decisions for your business Gain a 360-degree view of Seelos Therapeutics, Inc. and make more informed decisions for your business Find out more
Headquarters United States of America
Address 300 Park Avenue, 2nd Floor, New York, 10022
Website seelostherapeutics.com
Telephone 1 646 2932100
No of Employees 15
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange SEEL (NASD)
Revenue (2022) $2.2M
EPS XYZ
Net Income (2022) XYZ 48.5% (2022 vs 2021)
Market Cap* $4.1M
Net Profit Margin (2022) XYZ 0.0% (2022 vs 2021)
* As of and is in US$
View Seelos Therapeutics, Inc. financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Seelos Therapeutics, Inc. premium industry data and analytics

60+

Clinical Trials

Determine Seelos Therapeutics, Inc. go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

30+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Seelos Therapeutics, Inc.’s relevant decision makers and contact details.

30+

Pipeline Drugs

Identify which of Seelos Therapeutics, Inc.’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

30+

Catalyst Calendar

Proactively evaluate Seelos Therapeutics, Inc.’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

6

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

5

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

4

Marketed Drugs

Understand Seelos Therapeutics, Inc.’s commercialized product portfolio to stay one step ahead of the market.

Products and Services

Products
Pipeline
SLS-002- Major Depressive Disorder and Post-Traumatic Stress Disorder (PSTD)
SLS-004- Parkinson’s Disease
XYZ
XYZ
XYZ
Understand Seelos Therapeutics, Inc. portfolio and identify potential areas for collaboration Understand Seelos Therapeutics, Inc. portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Seelos Therapeutics, Inc. Pfizer Inc Eli Lilly and Co Teva Pharmaceutical Industries Ltd Sun Pharmaceutical Industries Ltd
Headquarters United States of America United States of America United States of America Israel India
City New York New York Indianapolis Tel Aviv Mumbai
State/Province New York New York Indiana Tel Aviv Maharashtra
No. of Employees 15 88,000 43,000 35,001 41,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Raj Mehra, Ph.D. Chairman; Chief Executive Officer Executive Board 2019 -
Richard W. Pascoe Director Executive Board 2013 -
Michael Golembiewski Chief Financial Officer Senior Management - -
Anthony Marciano Chief Communications Officer Senior Management - -
Tim Whitaker Chief Medical Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Seelos Therapeutics, Inc. key executives to enhance your sales strategy Gain insight into Seelos Therapeutics, Inc. key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code